Abstract B48: A phase 1 study of an antisense oligonucleotide against survivin (LY2181308) in Japanese patients with solid tumors
暂无分享,去创建一个
M. Tanioka | T. Tamura | N. Yamamoto | H. Nokihara | Kazuhiko Yamada | Y. Goto | Y. Nambu | K. Uenaka | R. Sekiguchi | Y. Yamada